These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 26699390)

  • 21. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.
    Kitai T; Grodin JL; Kim YH; Tang WH
    Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Palazzuoli A; Testani JM; Ruocco G; Pellegrini M; Ronco C; Nuti R
    Int J Cardiol; 2016 Dec; 224():213-219. PubMed ID: 27657476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluid removal in acute heart failure: diuretics versus devices.
    Krishnamoorthy A; Felker GM
    Curr Opin Crit Care; 2014 Oct; 20(5):478-83. PubMed ID: 25111680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study.
    Zheng J; Ambrosy AP; Bhatt AS; Collins SP; Flint KM; Fonarow GC; Fudim M; Greene SJ; Lala A; Testani JM; Varshney AS; Wi RSK; Sandhu AT
    JACC Heart Fail; 2024 Aug; 12(8):1381-1392. PubMed ID: 38678466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.
    Testani JM; Brisco MA; Kociol RD; Jacoby D; Bellumkonda L; Parikh CR; Coca SG; Tang WH
    Am J Med; 2015 Jul; 128(7):776-83.e4. PubMed ID: 25595470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diuretic lounge and the impact on hospital admissions for treatment of decompensated heart failure.
    Ioannou A; Browne T; Jordan S; Metaxa S; Mandal AKJ; Missouris CG
    QJM; 2020 Sep; 113(9):651-656. PubMed ID: 32251503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
    Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM
    Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF.
    Voors AA; Davison BA; Felker GM; Ponikowski P; Unemori E; Cotter G; Teerlink JR; Greenberg BH; Filippatos G; Teichman SL; Metra M;
    Eur J Heart Fail; 2011 Sep; 13(9):961-7. PubMed ID: 21622980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure.
    Griffin M; Rao VS; Fleming J; Raghavendra P; Turner J; Mahoney D; Wettersten N; Maisel A; Ivey-Miranda JB; Inker L; Tang WHW; Wilson FP; Testani JM
    Am J Cardiol; 2019 Dec; 124(11):1707-1711. PubMed ID: 31601358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.
    Testani JM; Brisco MA; Turner JM; Spatz ES; Bellumkonda L; Parikh CR; Tang WH
    Circ Heart Fail; 2014 Mar; 7(2):261-70. PubMed ID: 24379278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.
    Biegus J; Mebazaa A; Davison B; Cotter G; Edwards C; Čelutkienė J; Chioncel O; Cohen-Solal A; Filippatos G; Novosadova M; Sliwa K; Adamo M; Arrigo M; Lam CSP; Ter Maaten JM; Deniau B; Barros M; Čerlinskaitė-Bajorė K; Damasceno A; Diaz R; Gayat E; Kimmoun A; Pang PS; Pagnesi M; Saidu H; Takagi K; Tomasoni D; Voors AA; Metra M; Ponikowski P
    J Am Coll Cardiol; 2024 Jul; 84(4):323-336. PubMed ID: 39019527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes.
    Testani JM; Coca SG; McCauley BD; Shannon RP; Kimmel SE
    Eur J Heart Fail; 2011 Aug; 13(8):877-84. PubMed ID: 21693504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of haemodynamic changes measured by serial central venous saturation during ultrafiltration for acutely decompensated heart failure with diuretic resistance and change in renal function.
    Vazir A; Simpkin VL; Marino P; Ludman A; Banya W; Tavazzi G; Bastin AJ; Trenfield S; Ghori A; Alexander PD; Griffiths M; Price S; Sharma R; Cowie MR
    Int J Cardiol; 2016 Oct; 220():618-22. PubMed ID: 27391002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.